| Factor Information | |
|---|---|
| Data ID | 1008 |
| Factor | Beta-blocker, n (%) |
| Description | A detailed overview of patients' characteristics. (HEPA, health-enhancing physical activity.) |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | This study applied the International Physical Activity Questionnaire (IPAQ) to assess self-reported physical activity (PA) in patients with CHD and their association with exercise capacity and health-related quality of life (HrQoL). |
| p Value | 0.005 |
| Conclusion | In total, 393 (50.0%) patients reported health-enhancing physical activity (HEPA), 237 (30.2%) minimal activity and 156 (19.8%) inactivity. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 496 |
| CHD Type | isolated CHD |
| CHD Subtype | TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
| Reference | |
|---|---|
| PMID | 28274955 |
| Year | 2017 |
| Title | Physical activity in adults with congenital heart disease and associations with functional outcomes. |
| Sample | ||
|---|---|---|
| Population | adults | |
| Source | Questionnaires | |
| Region | München,Germany | |
| Method | questionnaire | |
| Race | Europe | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | Inactive group; Minimally active group(Treatment) | HEPA group(Control) |
| Number | 156 ； 237 | 393 |
| Age | 32.9±12.4 years (Inactive group) 31.8±12.5 years (Minimally active group) | 30.1±10.6 years |
| Gender (Male: Female) | 92:64; 122:115 | 237:156 |
| Marker Level | 51 (32.7%) ; 44 (18.6%) | 89 (22.6%) |
